Submit Content
Get the latest delivered to your inbox
Privacy Policy

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

    Committed to Reducing Greenhouse Gas Emissions for a Healthier World Image

    POSTED 

    04-24-20

    Committed to Reducing Greenhouse Gas Emissions for a Healthier World

    Stories @ Gilead

    Gilead views environmental stewardship as critical to help the company achieve its mission and last year announced a goal to reduce gr...

    Ramping Up Manufacturing to Help Address COVID-19 Image

    POSTED 

    04-14-20

    Ramping Up Manufacturing to Help Address COVID-19

    As the number of confirmed COVID-19 cases increased in Asia and began to spread to other regions around the world, a team of employees at Gilead’s manufacturing site in La Verne, California met in the early morning of Monday, Feb. 3.

    The topic of the meeting: How quickly could the site beg...

    An Open Letter from our Chairman and CEO Image

    POSTED 

    04-02-20

    An Open Letter from our Chairman and CEO

    Daniel O'Day

    When the news of the coronavirus first emerged, Gilead immediately began to investigate the potential of remdesivir, a medicine we had been studying for many years as part of our extensive research in antivirals. Remdesivir had never been approved for use but based on...

    Gilead Sciences Statement on Ensuring Continued Supply of HIV Medicine Amid Coronavirus Outbreak Image

    POSTED 

    03-25-20

    Gilead Sciences Statement on Ensuring Continued Supply of HIV Medicine Amid Coronavirus Outbreak

    For those with potentially immunosuppressing conditions, such as HIV, the uncertainty caused by the novel coronavirus pandemic can be particularly challenging. Gilead remains focused on ensuring that people living with or at risk for HIV have access to the medications and ...

    Profiles in Creating Possible: Bismay Mishra Advocates for Transgender Equity Image

    POSTED 

    03-19-20

    Profiles in Creating Possible: Bismay Mishra Advocates for Transgender Equity

    Stories @ Gilead

    Educating people about gender identities and sexual orientation can be challenging to navigate in any setting – let alone at a company with employees from diverse backgrounds al...

    Profiles in Creating Possible: Julie Di Paolo is on a Mission to Understand Rheumatoid Arthritis and Other Inflammatory Diseases Image

    POSTED 

    03-12-20

    Profiles in Creating Possible: Julie Di Paolo is on a Mission to Understand Rheumatoid Arthritis and Other Inflammatory Diseases

    Stories @ Gilead

    When Julie Di Paolo’s father was diagnosed with Crohn’s disease, an inflammatory condition with limited treatment options, it sparked curiosity and drive that have carried forwa...

    Profiles in Creating Possible: Staci Bush Helps Gilead Go Beyond Medicine to Address Barriers to HIV Care Through Partnerships Image

    POSTED 

    03-06-20

    Profiles in Creating Possible: Staci Bush Helps Gilead Go Beyond Medicine to Address Barriers to HIV Care Through Partnerships

    Stories @ Gilead

    Staci Bush can still remember the first time that she, while working as a physician’s assistant at an LGBTQ+ teen health center in Chicago, became aware of the term “single tablet ...

    Gilead Sciences Logo

    Gilead Sciences

    Gilead Sciences

    Join today and get the latest delivered to your inbox